background image

Regeneron Pharmaceuticals Clinical Trials

Find clinical trials for Regeneron Pharmaceuticals. Search for Regeneron Pharmaceuticals clinical trials in different cities and states across the United States.

Filter
Active & Responsive

A Study of DB-OTO, an Adeno-Associated Virus (AAV) Based Gene Therapy, in Children/Infants, Adolescents and Adults With Hearing Loss Due to Otoferlin Mutations

for
Congenital Hearing Loss Secondary to Biallelic Mutations of the Otoferlin Gene (OTOF),
Location: Boston MA, New York NY, Orlando FL, Jacksonville FL,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 0+

Code: NCT05788536

Phase1, Phase2, Recruiting
New

A Study to Evaluate How Pozelimab + Cemdisiran Combination Therapy Works in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Whose Current Treatment is Not Working Efficiently

for
Paroxysmal Nocturnal Hemoglobinuria
Location: Levis
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07154745

Phase3, Recruiting
New

Safety and Drug Concentrations of REGN20934 in Adults With Overweight or Obesity

for
Overweight or Obesity
Location: Glendale CA
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18 - 65

Code: NCT07594093

Phase1, Recruiting
New

A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread

for
Prostate Cancer
Location: Hackensack NJ
Sponsor: Regeneron Pharmaceuticals

Sex: Male

Age: 18+

Code: NCT07543055

Phase1, Recruiting
New

A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD

for
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD),
Location: Metairie LA, Georgetown TX, San Antonio TX, Coronado CA,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07527910

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) to Evaluate How Safe Long-term Treatment With Pozelimab + Cemdisiran Combination Therapy is and How Well it Works

for
Paroxysmal Nocturnal Hemoglobinuria
Location: Toronto
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT05744921

Phase3, Recruiting

A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma

for
Relapsed Refractory Multiple Myeloma (RRMM)
Location: Durham NC
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT05730036

Phase3, Recruiting

An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis (AD)

for
Adverse Pregnancy Outcomes, Atopic Dermatitis
Location: Boston MA
Sponsor: Regeneron Pharmaceuticals

Sex: Female

Age: 18 - 49

Code: NCT03936335

Recruiting

A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma

for
Monoclonal Gammopathy of Undetermined Significance (MGUS),
Location: Boston MA, Stony Brook NY, New York NY, Philadelphia PA,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06140524

Phase2, Recruiting

Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: New York NY, Tampa FL, Columbus OH, Atlanta GA,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT03761108

Phase1, Phase2, Recruiting